![]() Bionomics Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders. | ![]() Helix BioPharma Helix BioPharma is a biopharmaceutical company developing therapies in the field of immuno-oncology, based on its technological platform DOS47. | |||
Founding Date | Founding Date 1996 | Founding Date 2005 | Founding Date 1995 | Founding Date 1978 |
Type | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Eastwood, AU HQ | Locations Sassari, IT HQ Tramariglio, IT | Locations Richmond Hill, CA HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more |
Employees | Employees 7 | Employees 8 | Employees 7 | Employees 16,5612% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) $264k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) |
Gross profit | Gross profit $6.1m (FY, 2022) | Gross profit N/A | Gross profit $305k (FY, 2025) | Gross profit ₹115.8b (FY, 2026) |
Net income | Net income ($21.8m) (FY, 2022) | Net income N/A | Net income ($5.2m) (FY, 2025) | Net income ₹3.7b (FY, 2026) |
Funding | ||||
Total funding raised | Total funding raised $ 10.4m | Total funding raised $ 53k | Total funding raised $ 11.1m | Total funding raised N/A |

Helix BioPharma is a biopharmaceutical company developing therapies in the field of immuno-oncology, based on its technological platform DOS47.
View company
Biocon is a company that develops and manufactures biopharmaceutical products.
View company